Show simple item record

dc.contributor.authorSchoonees, Anel
dc.contributor.authorLombard, Martani J.
dc.contributor.authorMusekiwa, Alfred
dc.contributor.authorNel, Etienne
dc.contributor.authorVolmink, Jimmy
dc.identifier.citationSchoonees, A. et al. 2019. Ready-to-use therapeutic food (RUTF) for home-basednutritional rehabilitation of severe acute malnutrition inchildren from six months to five years of age. Cochrane database of systematic reviews, 2019(5): Article no CD009000. [ 10.1002/14651858.CD009000.pub3]en_US
dc.identifier.issn1469-493X (Online)
dc.description.abstractBackground Management of severe acute malnutrition (SAM) in children comprises two potential phases: stabilisation and rehabilitation. During the initial stabilisation phase, children receive treatment for dehydration, electrolyte imbalances, intercurrent infections and other complications. In the rehabilitation phase (applicable to children presenting with uncomplicated SAM or those with complicated SAM after complications have been resolved), catch‐up growth is the main focus and the recommended energy and protein requirements are much higher. In‐hospital rehabilitation of children with SAM is not always desirable or practical ‐ especially in rural settings ‐ and home‐based care can offer a better solution. Ready‐to‐use therapeutic food (RUTF) is a widely used option for home‐based rehabilitation, but the findings of our previous review were inconclusive. Objectives To assess the effects of home‐based RUTF used during the rehabilitation phase of SAM in children aged between six months and five years on recovery, relapse, mortality and rate of weight gain. Search methods We searched the following databases in October 2018: CENTRAL, MEDLINE, Embase, six other databases and three trials registers. We ran separate searches for cost‐effectiveness studies, contacted researchers and healthcare professionals in the field, and checked bibliographies of included studies and relevant reviews. Selection criteria Randomised controlled trials (RCTs) and quasi‐RCTs, where children aged between six months and five years with SAM were, during the rehabilitation phase, treated at home with RUTF compared to an alternative dietary approach, or with different regimens and formulations of RUTF compared to each other. We assessed recovery, deterioration or relapse and mortality as primary outcomes; and rate of weight gain, time to recovery, anthropometrical changes, cognitive development and function, adverse outcomes and acceptability as secondary outcomes. Data collection and analysis We screened for eligible studies, extracted data and assessed risk of bias of those included, independently and in duplicate. Where data allowed, we performed a random‐effects meta‐analysis using Review Manager 5, and investigated substantial heterogeneity through subgroup and sensitivity analyses. For the main outcomes, we evaluated the quality of the evidence using GRADE, and presented results in a 'Summary of findings' table per comparison. Main results We included 15 eligible studies (n = 7976; effective sample size = 6630), four of which were cluster trials. Eight studies were conducted in Malawi, four in India, and one apiece in Kenya, Zambia, and Cambodia. Six studies received funding or donations from industry whereas eight did not, and one study did not report the funding source. The overall risk of bias was high for six studies, unclear for three studies, and low for six studies. Among the 14 studies that contributed to meta‐analyses, none (n = 5), some (n = 5) or all (n = 4) children were stabilised in hospital prior to commencement of the study. One small study included only children known to be HIV‐infected, another study stratified the analysis for 'recovery' according to HIV status, while the remaining studies included HIV‐uninfected or untested children. Across all studies, the intervention lasted between 8 and 16 weeks. Only five studies followed up children postintervention (maximum of six months), and generally reported on a limited number of outcomes. We found seven studies with 2261 children comparing home‐based RUTF meeting the World Health Organization (WHO) recommendations for nutritional composition (referred to in this review as standard RUTF) with an alternative dietary approach (effective sample size = 1964). RUTF probably improves recovery (risk ratio (RR) 1.33; 95% confidence interval (CI) 1.16 to 1.54; 6 studies, 1852 children; moderate‐quality evidence), and may increase the rate of weight gain slightly (mean difference (MD) 1.12 g/kg/day, 95% CI 0.27 to 1.96; 4 studies, 1450 children; low‐quality evidence), but we do not know the effects on relapse (RR 0.55, 95% CI 0.30 to 1.01; 4 studies, 1505 children; very low‐quality evidence) and mortality (RR 1.05, 95% CI 0.51 to 2.16; 4 studies, 1505 children; very low‐quality evidence). Two quasi‐randomised cluster trials compared standard, home‐based RUTF meeting total daily nutritional requirements with a similar RUTF but given as a supplement to the usual diet (213 children; effective sample size = 210). Meta‐analysis showed that standard RUTF meeting total daily nutritional requirements may improve recovery (RR 1.41, 95% CI 1.19 to 1.68; low‐quality evidence) and reduce relapse (RR 0.11, 95% CI 0.01 to 0.85; low‐quality evidence), but the effects are unknown for mortality (RR 1.36, 95% CI 0.46 to 4.04; very low‐quality evidence) and rate of weight gain (MD 1.21 g/kg/day, 95% CI ‐ 0.74 to 3.16; very low‐quality evidence). Eight studies randomised 5502 children (effective sample size = 4456) and compared standard home‐based RUTF with RUTFs of alternative formulations (e.g. using locally available ingredients, containing less or no milk powder, containing specific fatty acids, or with added pre‐ and probiotics). For recovery, it made little or no difference whether standard or alternative formulation RUTF was used (RR 1.03, 95% CI 0.99 to 1.08; 6 studies, 4188 children; high‐quality evidence). Standard RUTF decreases relapse (RR 0.84, 95% CI 0.72 to 0.98; 6 studies, 4188 children; high‐quality evidence). However, it probably makes little or no difference to mortality (RR 1.00, 95% CI 0.80 to 1.24; 7 studies, 4309 children; moderate‐quality evidence) and may make little or no difference to the rate of weight gain (MD 0.11 g/kg/day, 95% CI −0.32 to 0.54; 6 studies, 3807 children; low‐quality evidence) whether standard or alternative formulation RUTF is used. Authors' conclusions Compared to alternative dietary approaches, standard RUTF probably improves recovery and may increase rate of weight gain slightly, but the effects on relapse and mortality are unknown. Standard RUTF meeting total daily nutritional requirements may improve recovery and relapse compared to a similar RUTF given as a supplement to the usual diet, but the effects on mortality and rate of weight gain are not clear. When comparing RUTFs with different formulations, the current evidence does not favour a particular formulation, except for relapse, which is reduced with standard RUTF. Well‐designed, adequately powered, pragmatic RCTs with standardised outcome measures, stratified by HIV status, and that include diarrhoea as an outcome, are neededen_US
dc.subjectChild, Preschoolen_US
dc.titleReady-to-use therapeutic food (RUTF) for home-basednutritional rehabilitation of severe acute malnutrition inchildren from six months to five years of ageen_US
dc.contributor.researchID25719815 - Lombard, Martani Johanni

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record